Orthogonal Biologics

Orthogonal Biologics, a spin-off from the University of Illinois Urbana-Champaign, is developing a COVID-19 therapy. Leveraging our expertise in protein engineering to create protein drugs that bind to the viral spike with high affinity and specificity for safe and effective treatment.